| View |
|
DR-XY45527
|
Pantoprazole (as Sodium Sesquihydrate)
|
Unbranded
|
20 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Beximco Pharmaceuticals Limited
|
Bangladesh
|
Renewal
|
25 July 2024
|
21 July 2029
|
| View |
|
DR-XY45528
|
Nicardipine hydrochloride
|
Cardionid
|
1mg/ mL (10mg/ 10mL)
|
Solution for Injection (IV)
|
-
|
Swiss Parenterals Pvt. Ltd.
|
India
|
Automatic Renewal
|
26 April 2021
|
27 July 2026
|
| View |
|
DR-XY45530
|
d-Alpha Tocopheryl Succinate + Ascorbic Acid + Zinc
|
Fortima
|
Formulation: Each Film-Coated Tablet contains
d-Alpha Tocopheryl Succinate (Vitamin E)-22IU Ascorbic Acid (equivalent to 574 mg Sodium Ascorbate) [Vitamin C]-500mg Zinc (equivalent to 27.5 mg Zinc Sulfate Monohydrate)-10mg
|
Film-Coated Tablet
|
-
|
UNILAB, Inc.
|
Philippines
|
Automatic Renewal
|
18 May 2021
|
02 August 2026
|
| View |
|
DR-XY45531
|
Pregabalin
|
Preneurin
|
75 mg
|
Capsule
|
Antiepileptic
|
Lupin Limited
|
India
|
Automatic Renewal
|
22 July 2021
|
28 July 2026
|
| View |
|
DR-XY45532
|
Pregabalin
|
Preneurin
|
150 mg
|
Capsule
|
Antiepileptic
|
Lupin Limited
|
India
|
Automatic Renewal
|
22 July 2021
|
28 July 2026
|
| View |
|
DR-XY45534
|
Bisoprolol Fumarate + Hydrochlorothiazide
|
Cobis
|
5 mg/6.25 mg
|
Film-Coated Tablet
|
-
|
AJU Pharm Co., Ltd.
|
Korea
|
-
|
20 May 2021
|
05 August 2026
|
| View |
|
DR-XY45537
|
Calcitriol
|
Citriol
|
3mcg/ g
|
Ointment
|
Anti-psoriasis
|
Genova Biotechniques Pvt. Ltd.
|
India
|
Automatic Renewal
|
18 August 2021
|
29 July 2026
|
| View |
|
DR-XY45543
|
Co-Amoxiclav
|
Koact 1.2
|
1 g/ 200 mg
|
Powder for Solution for Injection (IV)
|
AntibacteriaI (PeniciIIin/Beta-Lactamase Inhibitor Combination)
|
Aurobindo Pharma Ltd. (Unit III)
|
India
|
-
|
05 April 2022
|
19 August 2026
|
| View |
|
DR-XY45545
|
Fluconazole
|
Fluxar
|
2mg/ mL (200mg/ 100mL)
|
Solution for IV Infusion
|
-
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
Automatic Renewal
|
07 July 2021
|
05 August 2026
|
| View |
|
DR-XY45546
|
Bimatoprost + Timolol Maleate
|
Ganfort PF
|
300 mcg/5 mg per mL
|
Sterile Ophthalmic Solution (Drops)
|
-
|
Allergan Pharmaceuticals Ireland
|
Ireland
|
Initial (from Monitored Release)
|
10 November 2022
|
05 August 2026
|
| View |
|
DR-XY45550
|
Propranolol Hydrochloride
|
None
|
10mg
|
Film-Coated Tablet
|
Beta Adrenoceptor Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
21 September 2021
|
10 August 2026
|
| View |
|
DR-XY45551
|
Propranolol Hydrochloride
|
None
|
10mg
|
Film-Coated Tablet
|
Beta Adrenoceptor Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
14 June 2021
|
10 August 2026
|
| View |
|
DR-XY45552
|
Multivitamins + Iron + Lysine Hydrochloride + Buclizine Hydrochloride (see reverse for formulation)
|
Buclisyr
|
Formulation: Each capsule contains:
4000IU
Retinyl Acetate [Vitamin A]
Thiamine Nitrate (Vitamin B] Riboflavin (as Sodium) [Vitamin B2] Nicotinamide (Vitamin B3] Pyridoxine Hydrochloride [Vitamin B6) Cyanocobalamin (Vitamin B12] Cholecalciferol (Vitamin D3] Iron (as Sulfate Monohydrate) Lysine Hydrochloride Buclizine Hydrochloride
1.2mg 1mg 20mg 1.8mg 3mcg 200IU 12mg 30mg 25mg
|
Capsule
|
Vitamins and Mineral / Appetite stimulant
|
La Croesus Pharma, Inc.
|
Philippines
|
Automatic Renewal
|
14 July 2021
|
17 August 2026
|
| View |
|
DR-XY45555
|
Latanoprost + Timolol (as maleate)
|
Astimol
|
50mcg/ 5mg per mL
|
Ophthalmic Solution
|
Anti-glaucoma
|
Rafarm S.A.
|
Greece
|
Automatic Renewal
|
11 October 2021
|
08 December 2026
|
| View |
|
DR-XY45556
|
Latanoprost
|
Astapro
|
50mcg/ mL (0.005% w/v)
|
Ophthalmic Solution
|
Prostaglandin Analogue
|
Rafarm S.A.
|
Greece
|
Automatic Renewal
|
03 November 2021
|
08 December 2026
|
| View |
|
DR-XY45557
|
Trimetazidine hydrochloride
|
Trivasc
|
20mg
|
Film-Coated Tablet
|
Anti-Angina
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
29 July 2021
|
19 August 2026
|
| View |
|
DR-XY45558
|
Clonidine hydrochloride
|
Catagen
|
75mcg
|
Tablet
|
Antihypertensive
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
18 September 2021
|
16 September 2026
|
| View |
|
DR-XY45562
|
Salmeterol (Xinafoate) + Fluticasone Propionate
|
Flutiright S-250
|
50 mcg/250 mcg
|
Dry Powder For Inhalation In Capsule
|
Antiasthma
|
Biodeal Pharmaceuticals Pvt. Ltd.
|
India
|
Automatic Renewal
|
23 April 2021
|
18 August 2026
|
| View |
|
DR-XY45563
|
Salmeterol (Xinafoate) + Fluticasone Propionate
|
Flutiright S-500
|
50 mcg/500 mcg
|
Dry Powder For Inhalation In Capsule
|
Antiasthma
|
Biodeal Pharmaceuticals Pvt. Ltd.
|
India
|
Automatic Renewal
|
21 April 2021
|
18 August 2026
|
| View |
|
DR-XY45564
|
Salmeterol (Xinafoate) + Fluticasone Propionate
|
Flutiright S-100
|
50 mcg/100 mcg
|
Dry Powder For Inhalation In Capsule
|
Antiasthma
|
Biodeal Pharmaceuticals Pvt. Ltd.
|
India
|
Automatic Renewal
|
23 April 2021
|
18 August 2026
|